IBRX270115P00022000
IBRX Jan 15 2027 22.00 PutoptionOPRA
EODOct 14, 2026
11.97USD-9.318%(-1.23)31Vol43OI
Loading…
Underlying
Underlying Price
$8.48
Type
Put
Strike
22
Expiration
Jan 15, 2027
DTE
87d
Moneyness
ITM
Intrinsic
$13.52
IBRX 22 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Jan 15, 2027 | 87d | $11.97 | -9.32% | 31 | 43 |
| Jan 21, 2028 | 458d | $13.23 | +0.84% | 5 | 56 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.